Israel Active

Israel’s VBL Therapeutics has developed VB-201 – the first of a new class of oral anti-inflammatories called Lecinoxoids. VB-201 has the potential to treat immune-inflammatory diseases such as Psoriasis, Inflammatory Bowel Disease, Multiple Sclerosis, Rheumatoid Arthritis and more. The US FDA has also granted fast-track designation for VB-111, which treats GBM - an aggressive form of brain cancer.

Staff at Hadassah Medical Center in Jerusalem worked 16-hour shifts to meet the needs of 80 women who gave birth during the recent snowstorm. Rescue teams transported expectant mothers to the hospital and some MDA ambulances conveyed two pregnant women.

Israel Brain Technologies has signed an agreement with four US organizations to create a partnership in neuroscience research, and in particular Alzheimer's disease.

A new orthodontic system developed by Israeli Aerodentis straightens the teeth through gentle pulsating force, which moves the teeth gradually during sleep. Medical research shows this force is healthier and more efficient than applying constant pressure.

Israeli Yaffa Golan couldn’t find a solution to the foot pain caused by her diabetes, so she invented Medic Shoes - clinically-proven flexible shoes featuring vibrating motors that massage the sole of the foot. They relieve burning, cramping, tingling, circulation and the quality of sleep.

A quarter of a million women die of cervical cancer every year. Israel’s MobileOCT has developed an image enhancement device that can detect early stage cancer. MobileOCT just won a $100,000 investment in an Elevator World Tour event in Tel Aviv.

We reported the amazing optics work of Bar Ilan University Prof Zalevsky back in December. Now his achievements have been recognised by top country in the optical field – Germany.

Thanks to scientists at Hadassah Medical Center, a simple blood test will now detect the presence of harmful BRCA1 and BRCA2 mutations in otherwise healthy women. Gene expression profiling is far quicker, cheaper and more accurate than the previous method of full gene sequencing.

Technion scientists have made a breakthrough that will improve the accuracy and speed of calculating an individual’s genome. A focused low-power green laser slows down the flow of DNA nanopores to enable sensors to get a higher-resolution analysis of the proteins in the DNA.

Israel has participated in an international summit on dementia in London, England, bringing its know-how to bear on a disease that is set to treble globally by 2050.